MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
The New England Journal of Medicine Downloaded from nejm.org at SUNY UPSTATE MEDICAL CENTER on September 1, 2015. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2009 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at SUNY UPSTATE MEDICAL CENTER on September 1, 2015. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2009 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at SUNY UPSTATE MEDICAL CENTER on September 1, 2015. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2009 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at SUNY UPSTATE MEDICAL CENTER on September 1, 2015. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2009 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at SUNY UPSTATE MEDICAL CENTER on September 1, 2015. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2009 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org at SUNY UPSTATE MEDICAL CENTER on September 1, 2015. For personal use only. No other uses without permission. From the NEJM Archive. Copyright © 2009 Massachusetts Medical Society. All rights reserved.
Suggest Documents
Chapter 7: Idiopathic membranous nephropathy.
Cancer risk after cyclophosphamide treatment in idiopathic membranous nephropathy.
Comparison of prognostic, clinical, and renal histopathological characteristics of overlapping idiopathic membranous nephropathy and IgA nephropathy versus idiopathic membranous nephropathy.
Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
Idiopathic Membranous Nephropathy: Diagnostic and Therapeutic Challenges.
Two cases of idiopathic membranous nephropathy treated with rituximab.
Factors affecting the long-term outcomes of idiopathic membranous nephropathy.
The natural history and therapy of idiopathic membranous nephropathy.
Patient age and the prognosis of idiopathic membranous nephropathy.
Clinicopathological analysis of idiopathic membranous nephropathy in young adults.
TRPC6 single nucleotide polymorphisms and progression of idiopathic membranous nephropathy.
Therapy of tacrolimus combined with corticosteroids in idiopathic membranous nephropathy.
Shenqi particle: a novel therapy for idiopathic membranous nephropathy.
Idiopathic membranous nephropathy and anti-phospholipase A2 receptor antibodies.
Pathogenesis and treatment of membranous nephropathy.
Dissecting the relationships of IgG subclasses and complements in membranous lupus nephritis and idiopathic membranous nephropathy.
New onset psoriasis after rituximab for treatment of idiopathic membranous nephropathy.
Successful treatment of icodextrin-single peritoneal dialysis for refractory nephrotic syndrome induced by idiopathic membranous nephropathy.
Plasmapheresis combined with rituximab for refractory idiopathic membranous nephropathy.
Leflunomide in idiopathic membranous nephropathy: a new immunosuppressive with promising treatment potential.
Membranous nephropathy--still a treatment dilemma.
Membranous nephropathy in childhood and its treatment.
Clinicopathological features of idiopathic membranous nephropathy combined with IgA nephropathy: a retrospective analysis of 9 cases.
Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
Treatment of idiopathic membranous nephropathy.
The New England Journal of Medicine Downloaded from nejm.org at SUNY UPSTATE MEDICAL CENTER on September 1, 2015. For personal use only. No other uses...
2MB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Chapter 7: Idiopathic membranous nephropathy.
Cancer risk after cyclophosphamide treatment in idiopathic membranous nephropathy.
Comparison of prognostic, clinical, and renal histopathological characteristics of overlapping idiopathic membranous nephropathy and IgA nephropathy versus idiopathic membranous nephropathy.
Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
Idiopathic Membranous Nephropathy: Diagnostic and Therapeutic Challenges.
Two cases of idiopathic membranous nephropathy treated with rituximab.
Factors affecting the long-term outcomes of idiopathic membranous nephropathy.
The natural history and therapy of idiopathic membranous nephropathy.
Patient age and the prognosis of idiopathic membranous nephropathy.
Clinicopathological analysis of idiopathic membranous nephropathy in young adults.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms